capilliposide B

Term ID

CHEBI:65574

Synonyms

(3beta,16alpha,22alpha)-3-{[beta-D-glucopyranosyl-(1->2)-[beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)]-alpha-L-arabinopyranosyl]oxy}-16,28-dihydroxy-13,28-epoxyoleanan-22-yl hexanoate
22-caproylanagalligenin A-3-O-beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranoside

Definition

A triterpenoid saponin that consists of anagalligenin A substituted by a caproyl group at position 22 and a beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranosyl moiety at position 3 via a glycosidic linkage. It is isolated from the whole plants of Lysimachia capillipes and has been shown to exhibit potent cytotoxicity against human A-2780 cells.

References

PMID:16595968
Reaxys:10416641

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-L-arabinopyranoside bridged compound cyclic ether diol hexacyclic triterpenoid ... Show All 10 Terms

alpha-L-arabinopyranoside bridged compound cyclic ether diol hexacyclic triterpenoid hexanoate ester lactol secondary alcohol tetrasaccharide derivative triterpenoid saponin Show first 5 Terms
has_functional_parent: anagalligenin A

anagalligenin A Show first 5 Terms
has_parent_hydride: oleanane

oleanane Show first 5 Terms
has_role: antineoplastic agent plant metabolite

antineoplastic agent plant metabolite Show first 5 Terms

Phenotype

Phenotype resulting from capilliposide B

Phenotype where environments contain capilliposide B

Phenotype modified by environments containing capilliposide B

Human Disease Model